Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. - Wikidata - wikimedia - TriplyDB

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

http://www.wikidata.org/entity/Q37995993

about

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Management of hepatocellular carcinoma with portal vein thrombosis Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis.Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study.Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival.Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients.Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.Doxorubicin -eluting beads in the treatment of liver carcinoma.Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.Transarterial Chemoembolization for Hepatocellular Carcinomas with Central Bile Duct Invasion: Safety, Prognosis, and Predictive Factors.Current management of hepatocellular carcinoma: an Eastern perspective.Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ.Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis.Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma.Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma.

P2860

Q26771776-66E9840E-DD34-43B7-82EA-58D9FB004750 Q26799469-C5B3516C-8BFA-4630-A91C-7AED1205064B Q26851033-45513FA4-34B1-4FDC-8E9E-ADC3029C7AC5 Q26852174-E874D942-1AAC-439D-8C69-D7C2ABB1857C Q26996578-69E958F2-B416-4246-8975-A0B73AF95ED0 Q27013055-8FB3DE43-22EC-407A-A455-2E0FABD30A30 Q27022015-E89A084D-51FF-4229-BE01-87E45AA103BF Q33438161-B2391B38-2520-4F98-AB34-B426C5A59F35 Q33572657-21B67799-CE35-4E38-BBE4-CEEE52AD2ECE Q33590407-175FDC75-5C74-4106-B8F5-D76F2DE81E76 Q33627217-0F47D990-6E96-437A-A820-1EEFFFFB65EC Q33735369-AAC4C323-D7E3-4ADA-928C-30B72A2CCD6B Q33758258-53D3B04B-F716-4C13-A268-2FFA7C152199 Q33797067-63B3D312-5BDE-4E31-8781-7B0DD459C470 Q34458029-06A6F154-0806-4F30-AF1F-F87E9F0A950C Q34659148-1F8CBED4-0F8F-4D25-82E1-B01328D7394A Q34900004-079F5508-559C-4423-AF95-635F00F75433 Q35715947-898DB3AC-57E5-47A2-875A-B702CE8F070A Q35824064-8027A787-AF04-4D75-8261-5FD02723F51E Q36009432-B2331028-BE23-4EE6-9E72-22E6441E92A2 Q36195552-6F6D23CE-AA74-47E9-99E5-28C043B7C945 Q36272834-B28299BB-927E-4472-A511-5DC2D25DB1CB Q36312145-6C3D44C5-20C9-4B3C-9750-C286F9683294 Q36720696-CD9FA0D5-D5EF-4054-A2CD-F8445849FBED Q37253643-0B642142-3F86-4FF5-AC9C-A5EE1A1CB703 Q37687300-7CDCFB40-5F48-45A2-9025-DAEB5F39A9B3 Q37718937-98D58847-368C-42E5-9337-D8DB9E89F4A4 Q37722175-1E0DF820-CAB7-495E-93B0-DA9C26F08BF8 Q38109951-779788B6-F0B6-40F4-8EEB-4F7923AAF30B Q38113503-72E7D60D-FEF4-43F8-BCAA-FC718B9B3DC2 Q38161583-FB3D3917-DDEC-4C99-9824-5C44AB52D6AC Q38170197-1950B5F3-C655-40F1-BF07-4A10CB6795FD Q38281294-D2AB56A8-FCD4-4FCF-9D6D-7F9427D926CA Q38410816-10A2ED41-9F15-4AFF-B9E3-0E4542E44549 Q38608806-926198D3-795F-4395-B087-F605ADECA98B Q38810775-AB971A58-D98A-4FE8-A855-98EBB35B0631 Q38824638-98FCA50E-94A4-4645-97D8-CCF234B5E1FB Q39375746-712152CE-B2C5-4D06-A84C-AB315F759E47 Q39410889-0BEBA8FE-B9CC-46E8-A7A7-51E449DE50BD Q39434012-B6F5C3B1-6552-4BFA-80A5-E68BA3883393

P2860

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

http://www.wikidata.org/entity/Q37995993

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@en

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@nl

type

label

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@en

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@nl

prefLabel

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@en

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@nl

P1433

Q37995993-11CEE7E9-CFC2-41F0-8714-25F452E8EB3D

P1476

Q37995993-D5DBD52B-EB11-4C68-8627-90D37AAE5F2C

P2093

Q37995993-01BB29FA-CDDE-4FDC-AD1B-9F279409E68B

Q37995993-1FE302A0-CCF8-41E7-9016-5B0DB3DAF492

Q37995993-3007ED0C-D6BC-4709-AE73-01498D20B6C3

Q37995993-5E435DEA-6D49-4067-B97B-F8920C555B24

Q37995993-6264B101-BB59-4796-976A-4C2512D8C4FC

Q37995993-80369FA2-CC3E-4D28-B413-69E04A44FF07

Q37995993-8297A918-95AC-4570-96E2-BBED6147131C

Q37995993-85827229-7241-4507-B3DD-7D70E3E08A33

Q37995993-CCD92DBA-61CD-4D8B-9E90-9B7197995E30

Q37995993-D17656CE-40CF-43F6-92E7-CB6C0CAE75E8

P304

Q37995993-072E7F6A-2923-4E9C-A606-8C0B7E0DB8D1

P31

Q37995993-34030153-0889-4576-8F60-45152C8BE7F9

P356

Q37995993-7F9B17CF-AB5D-44AC-A768-8EC136014225

P407

Q37995993-3EDADB5D-996B-44EF-9D72-0C873CD27D59

P433

Q37995993-D5EB83AE-4355-4B38-885C-B85FE1A57106

P478

Q37995993-253EE9D7-624D-4DFD-A5CB-019D9F2C63FC

P50

Q37995993-20C81E1D-5BA3-48D5-9BC5-6B5779AFA7D1

P577

Q37995993-10C0C5CA-DE5F-426A-86BE-EF39F1DBCF41

P698

Q37995993-385FC411-6F13-495E-9CA8-AAFD620EE8B6

P356

RADIOL.12111550

P1433

P1476

Advanced-stage hepatocellular ...... embolization versus sorafenib.

@en

P2093

Andreas Maieron

http://www.w3.org/2001/XMLSchema#string

Birgit Grünberger

http://www.w3.org/2001/XMLSchema#string

Christian Müller

http://www.w3.org/2001/XMLSchema#string

Claus Kölblinger

http://www.w3.org/2001/XMLSchema#string

Florian Hucke

http://www.w3.org/2001/XMLSchema#string

Ivo Graziadei

http://www.w3.org/2001/XMLSchema#string

Matthias Pinter

http://www.w3.org/2001/XMLSchema#string

Robert Königsberg

http://www.w3.org/2001/XMLSchema#string

Rudolf Stauber

http://www.w3.org/2001/XMLSchema#string

Wolfgang Sieghart

http://www.w3.org/2001/XMLSchema#string

P304

590-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.12111550

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

263

http://www.w3.org/2001/XMLSchema#string

P50

Markus Peck-Radosavljevic

P577

2012-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22438359

http://www.w3.org/2001/XMLSchema#string